Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc., Epoch Holding Corporation, Somaxon Pharmaceuticals...

        






Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc., Epoch Holding Corporation, Somaxon Pharmaceuticals, Inc. and Young Innovations, Inc.

NEW YORK, Dec. 17, 2012 /PRNewswire/ --

Caribou Coffee Company, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Caribou Coffee Company, Inc. (Nasdaq: CBOU) to Joh. A. Benckiser Group for $16.00 per share in cash, or a total of approximately $340 million. 

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] Ext. 18 or by sending an e-mail including your contact information to: [e-mail].

Epoch Holding Corporation

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Epoch Holding Corporation (Nasdaq: EPHC) (referred to as "Epoch") to TD Bank Group for cash consideration of approximately $668 million.  Pursuant to the merger agreement, each Epoch stockholders will receive $28.00 in cash per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] Ext. 18 or by sending an e-mail including your contact information to: [e-mail].

Somaxon Pharmaceuticals, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) (referred to as "Somaxon") to Pernix Therapeutics Holdings, Inc. (referred to as "Pernix").  Under the terms of the agreement, Somaxon stockholders will receive aggregate consideration equal to $25 million in Pernix common stock.  The number of shares of Pernix common stock to be issued to the stockholders of Somaxon will be based on the volume-weighted average price of Pernix's common stock over the 30 day period ending on the day immediately prior to the closing of the proposed merger, subject to limitations on the maximum and minimum number of shares of Pernix common stock issuable in the transaction based on a price range of $6.00 to $9.00 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] Ext. 18 or by sending an e-mail including your contact information to: [e-mail].

Young Innovations, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Young Innovations, Inc. (Nasdaq: YDNT) (referred to as "Young") to an affiliate of Linden Capital Partners (referred to as "Linden Capital") in a cash transaction.  Under the terms of the agreement, holders of outstanding shares of common stock of Young will receive $39.50 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] Ext. 18 or by sending an e-mail including your contact information to: [e-mail].

Lifshitz Law Firm is a New York based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions.  For more information about the firm, please visit our website at www.jlclasslaw.com.

ATTORNEY ADVERTISING. © 2012 Lifshitz Law Firm.  The law firm responsible for this advertisement is Lifshitz Law Firm, 18 East 41^st Street, New York, New York 10017, [phone].  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm
Phone:   [phone]
Email: [e-mail]

SOURCE Lifshitz Law Firm

Copyright 2012 PR Newswire